Stahler, Arndt; Stintzing, Sebastian; Modest, Dominik Paul et al.
Association of MAPK signaling subtypes with prognostic benefit for bevacizumab in left-sided metastatic colorectal cancer (mCRC) patients treated with FOLFIRI plus cetuximab / bevacizumab (FIRE-3 trial).JOURNAL OF CLINICAL ONCOLOGY. Bd. 37. H. 15. 2019
Miller-Phillips, Lisa; Heinemann, Volker; Stahler, Arndt et al.
Association of microRNA-21 with efficacy of cetuximab in RAS wild-type patients in the FIRE-3 study (AIO KRK-0306) and microRNA-21's influence on gene expression in the EGFR signaling pathway.JOURNAL OF CLINICAL ONCOLOGY. Bd. 37. H. 15. 2019
Frommer, Lara; Kahaly, George J.
Autoimmune PolyendocrinopathyJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. Bd. 104. H. 10. 2019 S. 4769-4782
De Gramont, A.; Henriques, J.; Baruch, B. et al.
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (CC): Updated analysis of stage II disease from the AVANT phase III randomized trial by the GERCOR groupANNALS OF ONCOLOGY. Bd. 30. 2019
Galle, Peter R.; Foerster, Friedrich; Kudo, Masatoshi et al.
Biology and significance of alpha-fetoprotein in hepatocellular carcinomaLIVER INTERNATIONAL. Bd. 39. H. 12. 2019 S. 2214-2229
Galle, Peter R.; Foerster, Friedrich; Kudo, Masatoshi et al.
Biology and significance of alpha-fetoprotein in hepatocellular carcinomaLIVER INTERNATIONAL. 2019
Eelbode, Tom; Hassan, Cesare; Demedts, Ingrid et al.
BLI AND LCI IMPROVE POLYP DETECTION AND DELINEATION ACCURACY FOR DEEP LEARNING NETWORKSGASTROINTESTINAL ENDOSCOPY. Bd. 89. H. 6. 2019 S. AB632-AB632
Castven, Darko; Czauderna, Carolin; Becker, Diana et al.
Cancer stem cell sub-population drives treatment resistance to anti-angiogenic drugs in hepatocellular carcinomaINTERNIST. Bd. 60. 2019 S. S18-S18
Labenz, Christian; Prochaska, Juergen H.; Huber, Yvonne et al.
Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low-Density Lipoprotein CholesterolHEPATOLOGY COMMUNICATIONS. Bd. 3. H. 11. 2019 S. 1472-1481
Czauderna, Carolin; Poplawski, A.; Castven, D. et al.
Characterization of the (epi)genetic alterations during liver cancer development and progression.INTERNIST. Bd. 60. 2019 S. S14-S15